The Promise of Senolytic Therapies
The Cutting Edge of Senolytics: New Developments in Removing Harmful Senescent Cells Senolytics...
Read More
AI Unlocks New Frontier in Anti-Aging Medicine
Cutting-edge AI drug discovery techniques are unveiling promising novel senolytic compounds that could translate into significant anti-aging and longevity treatments.
Read More
Reversing Aging in Stem Cells
SenolyticsShop.com is proud to share the exciting news of a new drug delivery method that can reverse the senescence of stem cells. As people age, their bodies begin to change and deteriorate due to a process known as senescence.
Read MoreFighting aging with immune checkpoint blockade
Nature Reviews Drug Discovery – Discover the world’s best science and medicine |...
Read MoreDespite Their Scary Name, Some ‘Zombie’ Cells May Not Be All Bad
There’s a good zombie.
Read MoreFocus on frailty: New senolytic holds potential for sarcopenia treatment
Buck Institute professor shifts focus to functional studies of senolytic compound with hopes for frailty and sarcopenia.
Read MoreProgress in Emerging Alzheimer’s Therapeutics Based on Biology of Aging to be Highlighted in Session Moderated by Alzheimer’s Drug Discovery Foundation (ADDF) at 2022 Clinical Trials on Alzheimer’s Disease Conference
The Alzheimer’s Drug Discovery Foundation will be moderating a session, “Beyond Amyloid and Tau: Emerging Solutions,” at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference, which will be...
Read MoreSenolytic treatment shows promise in DME, wet AMD
FORT LAUDERDALE, Fla. — A senolytic therapy represents a novel approach to treating diabetic macular edema and wet age-related macular degeneration, according to a speaker at the Retina World Congress. Raj Maturi, MD, presented...
Read MoreGlobal Senolytic Drugs Market Research Report 2022: Voice of Customer, Clinical Trials, Patent Analysis, Outlook, Market Dynamics, Trends & Developments, Competitive Landscape
Dublin, May 20, 2022 (GLOBE NEWSWIRE) — The “Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine…
Read MoreA Glb1-2A-mCherry reporter monitors systemic aging and predicts lifespan in middle-aged mice
Nature Communications – Monitoring the aging process in vivo is challenging. Here the authors generate a Glb1+/m‒Glb1-2A-mCherry (GAC) reporter mouse model, where the GAC signal is…
Read MoreSenolytics to Tackle Age-Related Pathologies
The world is rapidly aging. According to the World Health Organization, 12% of the world population was aged 60 and above in 2015 and by 2050, that number will rise to 22%. Along with this demographic shift, there is an increase...
Read MoreBuck Institute research reveals potential new class of senolytics
A naturally-occurring metabolite has senolytics potential in both mice and human cell culture, showing particular efficacy in skeletal muscle.
Read More
